SEC Form 4 · accession 0001651844-18-000018
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Oct 31, 2018
Accepted (ET)
Nov 1, 2018 · 3:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 31, 2018 | P | 6,000 | $1.7944 | A | 3,190,550 | D | |
| Common Stock | Oct 31, 2018 | P | 6,000 | $1.7888 | A | 3,196,550 | D |
Table II — derivative securities
No Table II lines on this filing.